These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30483395)

  • 1. The effects of crocetin, extracted from saffron, in chemotherapy against the incidence of multiple drug resistance phenotype.
    Neyshaburinezhad N; Hashemi M; Ramezani M; Arabzadeh S; Behravan J; Kalalinia F
    Iran J Basic Med Sci; 2018 Nov; 21(11):1192-1197. PubMed ID: 30483395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encapsulation of crocetin into poly (lactic-co-glycolic acid) nanoparticles overcomes drug resistance in human ovarian cisplatin-resistant carcinoma cell line (A2780-RCIS).
    Neyshaburinezhad N; Kalalinia F; Hashemi M
    Mol Biol Rep; 2019 Dec; 46(6):6525-6532. PubMed ID: 31646427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crocin suppresses multidrug resistance in MRP overexpressing ovarian cancer cell line.
    Mahdizadeh S; Karimi G; Behravan J; Arabzadeh S; Lage H; Kalalinia F
    Daru; 2016 Jun; 24(1):17. PubMed ID: 27342070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
    Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
    Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucosamine reverses drug resistance in MRP2 overexpressing ovarian cancer cells.
    Valinezhad Sani F; Palizban A; Mosaffa F; Jamialahmadi K
    Eur J Pharmacol; 2020 Feb; 868():172883. PubMed ID: 31866406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Multidrug Resistance Protein 2 Efflux in the Cisplatin Resistance Human Ovarian Carcinoma Cells A2780/RCIS by Sesquiterpene Coumarins.
    Kasaian J; Mosaffa F; Behravan J; Masullo M; Piacente S; Iranshahi M
    Phytother Res; 2016 Jan; 30(1):84-9. PubMed ID: 26503061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin.
    Wortelboer HM; Usta M; van der Velde AE; Boersma MG; Spenkelink B; van Zanden JJ; Rietjens IM; van Bladeren PJ; Cnubben NH
    Chem Res Toxicol; 2003 Dec; 16(12):1642-51. PubMed ID: 14680379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel quinoline analogs of ketoprofen as multidrug resistance protein 2 (MRP2) inhibitors.
    Mosaffa F; Hadizadeh F; Fathi F; Eslami Nasab Z; Pourzahed T; Aboutorabzade SM; Ghodsi R
    Iran J Basic Med Sci; 2021 Jun; 24(6):815-825. PubMed ID: 34630959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cx32 mediates cisplatin resistance in human ovarian cancer cells by affecting drug efflux transporter expression and activating the EGFR‑Akt pathway.
    Zhang Y; Tao L; Fan LX; Huang K; Luo HM; Ge H; Wang X; Wang Q
    Mol Med Rep; 2019 Mar; 19(3):2287-2296. PubMed ID: 30664215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques.
    Jekerle V; Klinkhammer W; Scollard DA; Breitbach K; Reilly RM; Piquette-Miller M; Wiese M
    Int J Cancer; 2006 Jul; 119(2):414-22. PubMed ID: 16646006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
    Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
    Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saikosaponin b2 enhances the hepatotargeting effect of anticancer drugs through inhibition of multidrug resistance-associated drug transporters.
    Zhao Y; Feng L; Liu L; Zhao R
    Life Sci; 2019 Aug; 231():116557. PubMed ID: 31194994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
    Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH
    Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of in vitro cellular MRP1 and MRP2 mediated vincristine resistance by the flavonoid myricetin.
    van Zanden JJ; de Mul A; Wortelboer HM; Usta M; van Bladeren PJ; Rietjens IM; Cnubben NH
    Biochem Pharmacol; 2005 Jun; 69(11):1657-65. PubMed ID: 15896345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of the multidrug resistance protein MRP1 gene in acute myeloid leukemia: the impact on MRP activity.
    van Der Kolk DM; Vellenga E; van Der Veen AY; Noordhoek L; Timmer-Bosscha H; Ossenkoppele GJ; Raymakers RA; Müller M; van Den Berg E; de Vries EG
    Blood; 2000 Jun; 95(11):3514-9. PubMed ID: 10828037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of multi-drug resistance of ovarian carcinoma by small interfering RNA targeting to MRP2 gene.
    Ma JJ; Chen BL; Xin XY
    Arch Gynecol Obstet; 2009 Feb; 279(2):149-57. PubMed ID: 18584188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
    Ma JJ; Chen BL; Xin XY
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines.
    Januchowski R; Sterzyńska K; Zaorska K; Sosińska P; Klejewski A; Brązert M; Nowicki M; Zabel M
    J Ovarian Res; 2016 Oct; 9(1):65. PubMed ID: 27756418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
    Wang W; Ke S; Chen G; Gao Q; Wu S; Wang S; Zhou J; Yang X; Lu Y; Ma D
    Oncol Rep; 2004 Dec; 12(6):1365-70. PubMed ID: 15547764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between p-cofilin and cisplatin resistance in patients with ovarian cancer and the role of p-cofilin in prognosis.
    Qin Y; Li W; Long Y; Zhan Z
    Cancer Biomark; 2019; 24(4):469-475. PubMed ID: 30932883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.